Condition | Gene signature | Endometrial staging | Participants | Platform | Threshold | No. genes | References |
---|---|---|---|---|---|---|---|
Endometrial progression | Altmäe2017 | N/A | N/A | N/A | RRA | 57 | [34] |
Borthwick | Urinary LH; Histologically confirmed | PF d9-11 (n = 5) vs R LH + 6–8 (n = 5) | Affymetrix Genechip Hu95A | N/A | 116 | [18] | |
Carrascosa | N/A | N/A | Quantitative RT-PCR | Based on literature | 187 | [35] | |
Carson | Urinary LH; Histologically confirmed | ESE LH + 2–4 (n = 3) vs MSE LH + 7–9 (n = 3) | Affymetrix Genechip Hu95A | |FC|> 2 | 695 | [17] | |
Diaz-Gimeno | Urinary LH | PR LH + 1–5 (n = 15) vs R | Agilent custom gene expression microarray | |FC| > 2 | 234 | [36] | |
Kao | Urinary LH; Histologically confirmed | LPF d8-10 (n = 4) vs MSE LH + 8-10 (n = 7) | Affymetrix Genechip Hu95A | |FC|> 2 and P-value <0.05 | 340 | [37] | |
Mirkin | Urinary LH; Histological dating | ESE LH + 3 (n = 3) vs MSE LH + 8 (n = 5) | Affymetrix Genechip Hu95A | |FC|>2 and adj-P-value < 0.05 | 105 | [19] | |
Ponnampalam | Histological dating | EPF (n = 5) MPF (n = 7) LPF (n = 3) ESE (n = 7) MSE (n = 8) LS (n = 7) Mense (n = 6) | Custom | Adj-P-value <0.05 | 306 | [38] | |
Punyadeera | Histological dating | Mense (n = 2) vs LPF (n=2) | Affymetrix HG-U133A | FC and P-value | 50 | [39] | |
Riesewijk | Urinary LH; Histological dating | PR LH + 2 (n = 5) vs R LH + 7 (n = 5) | Affymetrix Genechip Hu95A | |FC|> 3 in at least four out of five women. | 196 | [40] | |
Talbi | Histological dating | P (n = 6) vs ESE (n = 3) vs MSE (n = 8) vs LSE (n = 6) | Affymetrix HG-U133 Plus 2.0 | |FC|> 1.5 and adj-P-value < 0.05 | 317 | [4] | |
Implantation failure | Altmäe2010 | Urinary LH | UI (n = 4) vs C (n = 5) | Whole Human Genome Oligo Microarray (Agilent Technologies) | |FC|> 2 and PFP < 0.05 | 184 | [21] |
Bastu | 6-7 days after LH surge | IF (n = 24) vs Fertile women (n = 24) | Agilent-039494 SurePrint G3 Human GE v2 8x60K | Log2(FC) ≥ 1 and adj-P-value ≤0.05 |FC|> 2 and PFP < 0.05 | 524 | [41] | |
Bersinger | N/A | IF (n = 3) vs M (n = 3) vs OP (n = 3) | Affymetrix Human Genome U133A 2.0 Chips | Not specified | 93 | [42] | |
Bhagwat | N/A | PR vs R | Multiple platforms | Based on literature | 177 | [43] | |
Koot | Urinary LH | RIF (n = 43) vs C (n = 72) | Human whole genome gene expression microarrays V2 (Agilent, Belgium) | Machine learning predictor | 310 | [44] | |
Lédée | Ultrasound evaluation | IF (n = 30) vs Fertile women (n = 15) | Affymetrix Human Genome U133 Plus 2.0 Array | Adj-P-value <0.01 and Δ > 1.35 | 322 | [45] | |
Pathare | 6-7 days after hCG administration | IF (n = 10) vs Healthy oocyte donors (n = 8) | Illumina HumanHT-12 V4.0 expression beadchip | |FC|> 2 | 818 | [46] | |
Shi | Urinary LH; Ultrasound evaluation | RIF (n = 12) vs C (n = 10) | Agilent-052909 CBC lncRNAmRNA V3 | |FC|≥ 2 and adj-P-value ≤ 0.05 | 281 | [47] |